Salt Lake City, UT—A new report from GOED, the Global Organization for EPA and DHA Omega-3s, provides a comprehensive overview of the latest studies on EPA and DHA omega-3s and their effects on specific brain health outcomes. The report was created with the help of GOED’s Clinical Study Database (CSD). This tool was developed by GOED to compile and organize all human clinical studies related to EPA and DHA. 

The report aims to offer valuable insights into the current state of science on brain health, as well as identify research gaps and propose potential directions for future projects or product innovations. The report offers an overview of the breadth and scope of studies published on:

  • cognitive health
  • stress
  • anxiety
  • mood
  • depression
  • Alzheimer’s disease
  • ADHD
  • and more... 

“Leveraging the immense capabilities of our CSD, GOED was able to streamline the process of data collection and analysis,” said Kaitlin Roke, Ph.D., GOED Director of Scientific Communication and Outreach. “We calculated that by using the Clinical Study Database to put this report together, we saved approximately 30 hours of work compared to employing a traditional academic search strategy.” 

The report is now available for sale on the GOED website for $199. GOED members have free access to the report.

Related: Study: Middle-Aged Adults with Low Omega-3 Index Have Smaller Brains that Have Aged Faster

GOED Report: Value of Omega-3s Ingredients Increased to $1.53B

Article on GOED Clinical Study Database Methodology Published